Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Shereen Sodder

Biographic Data

ID9671182
NAMEShereen Sodder
GIVEN NAMESShereen
FAMILY NAMESodder
SIGNATURESODDER S
AFFILIATIONSDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA
ORCID0000-0001-8254-0390
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2024
H-INDEX0
  • Beliefs and Attitudes about Vermont’s Buprenorphine Decriminalization Law among Clinicians Who Prescribe Buprenorphine

    Kenneth A Feder, Lauren Byrne et al.•ARTICLE•Substance Use & Misuse•2024

    BACKGROUND: On June 1, 2021, Vermont repealed all criminal penalties for possessing 224 milligrams or less of buprenorphine. We examined the potential impact of decriminalization with a survey of Vermont clinicians who prescribed buprenorphine within the past year. METHODS: All 638 Vermont clinicians with a waiver to prescribe buprenorphine were emailed the survey by Vermont Department of Health; 117 responded. We estimated the prevalence of the …

  • Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement

    Abigail K Winiker, Omeid Heidari et al.•ARTICLE•Substance Use & Misuse•2023

    Background: Medication for Opioid Use Disorder (MOUD) is a best practice for treating individuals with opioid use disorder (OUD), and primary care-based MOUD management can reduce treatment barriers among OUD patients. Individuals with OUD experience disproportionately high rates of trauma and violence, highlighting the importance of addressing trauma, mental health, and substance use concurrently. However, clear guidelines for trauma-informed tr…

No prominent works on this page.

  • Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement

    Abigail K Winiker, Omeid Heidari et al.•ARTICLE•Substance Use & Misuse•2023

    Background: Medication for Opioid Use Disorder (MOUD) is a best practice for treating individuals with opioid use disorder (OUD), and primary care-based MOUD management can reduce treatment barriers among OUD patients. Individuals with OUD experience disproportionately high rates of trauma and violence, highlighting the importance of addressing trauma, mental health, and substance use concurrently. However, clear guidelines for trauma-informed tr…

  • Beliefs and Attitudes about Vermont’s Buprenorphine Decriminalization Law among Clinicians Who Prescribe Buprenorphine

    Kenneth A Feder, Lauren Byrne et al.•ARTICLE•Substance Use & Misuse•2024

    BACKGROUND: On June 1, 2021, Vermont repealed all criminal penalties for possessing 224 milligrams or less of buprenorphine. We examined the potential impact of decriminalization with a survey of Vermont clinicians who prescribed buprenorphine within the past year. METHODS: All 638 Vermont clinicians with a waiver to prescribe buprenorphine were emailed the survey by Vermont Department of Health; 117 responded. We estimated the prevalence of the …

Family medicine (2 works) · Medicine (2 works) · Opioid (2 works) · Opioid Use Disorder Treatment (2 works) · Psychiatry (2 works) · Buprenorphine (1 work) · Decriminalization (1 work) · Emergency and Acute Care Studies (1 work) · Gun Ownership and Violence Research (1 work) · HIV, Drug Use, Sexual Risk (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae